Literature DB >> 15743760

Acid sphingomyelinase is indispensable for UV light-induced Bax conformational change at the mitochondrial membrane.

Hamid Kashkar1, Katja Wiegmann, Benjamin Yazdanpanah, Dirk Haubert, Martin Krönke.   

Abstract

Ultraviolet light-induced apoptosis can be caused by DNA damage but also involves immediate-early cell death cascades characteristic of death receptor signaling. Here we show that the UV light-induced apoptotic signaling pathway is unique, targeting Bax activation at the mitochondrial membrane independent of caspase-8 or cathepsin D activity. Cells deficient in acid sphingomyelinase (ASMase) do not show UV light-induced Bax activation, cytochrome c release, or apoptosis. In ASMase-deficient cells, the apoptotic UV light response is restored by stable or transient expression of human ASMase. Bax conformational change in ASMase(-/-) cells is also caused by synthetic C(16)-ceramide acting on intact cells or isolated mitochondria. The results suggest that UV light-triggered ASMase activation is essentially required for Bax conformational change leading to mitochondrial release of pro-apoptotic factors like cytochrome c and Smac.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743760     DOI: 10.1074/jbc.M410869200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis.

Authors:  Vincent Mignard; Nolwenn Dubois; Didier Lanoé; Marie-Pierre Joalland; Lisa Oliver; Claire Pecqueur; Dominique Heymann; François Paris; François M Vallette; Lisenn Lalier
Journal:  J Lipid Res       Date:  2020-04-29       Impact factor: 5.922

Review 2.  Ceramide-rich platforms in transmembrane signaling.

Authors:  Branka Stancevic; Richard Kolesnick
Journal:  FEBS Lett       Date:  2010-02-20       Impact factor: 4.124

3.  The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis.

Authors:  Leah J Siskind; Thomas D Mullen; Kimberly Romero Rosales; Christopher J Clarke; María José Hernandez-Corbacho; Aimee L Edinger; Lina M Obeid
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

4.  Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA.

Authors:  Sergei A Novgorodov; Bill X Wu; Tatyana I Gudz; Jacek Bielawski; Tatiana V Ovchinnikova; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

Review 5.  Recent advances in the immunobiology of ceramide.

Authors:  Saumya Pandey; Richard F Murphy; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2006-10-12       Impact factor: 3.362

Review 6.  Metabolic Regulation of Apoptosis in Cancer.

Authors:  K Matsuura; K Canfield; W Feng; M Kurokawa
Journal:  Int Rev Cell Mol Biol       Date:  2016-07-30       Impact factor: 6.813

Review 7.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

8.  Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells.

Authors:  Junfei Jin; Qi Hou; Thomas D Mullen; Youssef H Zeidan; Jacek Bielawski; Jacqueline M Kraveka; Alicja Bielawska; Lina M Obeid; Yusuf A Hannun; Yi-Te Hsu
Journal:  J Biol Chem       Date:  2008-08-01       Impact factor: 5.157

9.  Elevated XIAP expression alone does not confer chemoresistance.

Authors:  J M Seeger; K Brinkmann; B Yazdanpanah; D Haubert; C Pongratz; O Coutelle; M Krönke; H Kashkar
Journal:  Br J Cancer       Date:  2010-05-18       Impact factor: 7.640

10.  Lysosomal ceramide mediates gemcitabine-induced death of glioma cells.

Authors:  Claudia A Dumitru; Ibrahim E Sandalcioglu; Marek Wagner; Michael Weller; Erich Gulbins
Journal:  J Mol Med (Berl)       Date:  2009-09-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.